Sundowning in Dementia: What Caregivers Need to Know
Share
By Heather Robbins, Founder — Robbins Nest Alliance
Sundowning is one of the most disruptive and least understood features of dementia caregiving. It has a name, a mechanism, a documented prevalence, and an evidence base for management. This article covers all of it — sourced entirely from peer-reviewed literature — so caregivers can make informed decisions alongside their medical teams.
This is the clinical companion to our Nesting Journal post — the same topic from a caregiver's lived experience. If you want the human side first, start there. If you want the science, you're in the right place.
Watch: Sundowning Explained
Definition and Clinical Presentation
Sundowning — also called late-day confusion or sundown syndrome — refers to the emergence or worsening of behavioral and psychological symptoms of dementia (BPSD) in the late afternoon and early evening hours. It is not a standalone diagnosis but a recognized clinical phenomenon associated with multiple dementia subtypes including Alzheimer's disease, Lewy body dementia, vascular dementia, and frontotemporal dementia.
Common presentations include:
- Increased agitation and restlessness
- Confusion and disorientation to time, place, or person
- Suspicion or paranoia
- Pacing or wandering
- Emotional lability — rapid cycling between distress, anger, or tearfulness
- Resistance to caregiving tasks that were tolerated earlier in the day
Symptoms typically peak between approximately 3:00 PM and 8:00 PM, with the most acute window commonly falling in the late afternoon. Onset can precede formal dementia diagnosis and may worsen as the disease progresses.
Prevalence
Prevalence estimates vary significantly across studies due to differences in diagnostic criteria, care settings, and dementia subtype. A comprehensive review published in Frontiers in Medicine found that sundowning affects up to 66% of people with dementia — with rates varying by population, setting, and how the syndrome is operationally defined. A review in Psychiatry Investigation similarly documented a wide range depending on whether community-dwelling or institutionalized populations were studied.
The clinical takeaway: sundowning is not rare. It is one of the most common behavioral features of moderate-to-advanced dementia, and caregivers who are experiencing it are in the majority, not the exception.
Pathophysiology: Why This Happens
The mechanism driving sundowning is not fully characterized, but the leading evidence points to disruption of the circadian timing system — specifically degeneration of the suprachiasmatic nucleus (SCN) of the hypothalamus, which serves as the brain's primary biological clock.
In healthy individuals, the SCN coordinates circadian rhythms across the body: sleep-wake cycles, cortisol release, core body temperature fluctuation, and melatonin secretion. In dementia, particularly Alzheimer's disease, the SCN undergoes progressive neurodegeneration. The result is a circadian system that loses its ability to anchor the individual in time and regulate arousal appropriately across the day.
Volicer and colleagues documented this connection directly in a study published in the American Journal of Psychiatry, demonstrating measurable circadian rhythm disruption in Alzheimer's patients that correlated with sundowning symptom patterns. Animal model research published in Experimental Neurology further confirmed that circadian dysregulation — not behavioral dysregulation — is the primary driver.
Contributing factors identified in the literature include:
- Reduced melatonin production. Melatonin secretion declines significantly in Alzheimer's disease, disrupting the normal evening wind-down signal.
- Retinal degeneration. Light signals that entrain the circadian clock are processed through the retinohypothalamic tract. Retinal changes in aging and dementia impair this input pathway.
- Accumulated cognitive fatigue. Compensatory cognitive effort throughout the day depletes neural reserves, reducing the brain's capacity to maintain orientation and behavioral regulation by late afternoon.
- Environmental light reduction. Decreasing natural light in the late afternoon removes an external zeitgeber — a time cue — that partially compensates for impaired internal timing.
- Neurochemical shifts. Cholinergic deficits, which are central to Alzheimer's pathology, may contribute to the time-specific pattern of symptom emergence.
Relevance to TBI, CTE, and Parkinsonism
While sundowning research is most concentrated in Alzheimer's disease populations, the underlying circadian disruption mechanism is relevant across neurodegenerative conditions. Traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), and Parkinsonism all involve structural and functional changes to brain regions that govern sleep-wake regulation, including the hypothalamus, brainstem, and basal ganglia.
Caregivers supporting veterans or others with TBI-related neurodegeneration frequently report late-day behavioral escalation consistent with sundowning phenomenology, even when a formal dementia diagnosis is absent. This is an under-researched area. For veteran-specific resources, see our Veterans blog.
For foundational education on CTE and its relationship to dementia, see our Nest Academy CTE resources.
Evidence-Based Management Approaches
There is no pharmacological cure for sundowning. Current clinical guidance emphasizes non-pharmacological interventions as first-line, with medication reserved for cases where behavioral symptoms present safety risks and non-drug approaches have been exhausted. The National Institute on Aging explicitly recommends this sequencing.
Light Therapy
The strongest evidence base for non-pharmacological sundowning management is bright light therapy. A Cochrane systematic review — Forbes et al., Cochrane Database of Systematic Reviews, 2014 — found that structured light therapy improved cognition, sleep quality, activities of daily living, and behavioral disturbances in dementia patients. Morning exposure to bright light (10,000 lux, 30–60 minutes) is the most studied protocol. The mechanism is direct: morning light exposure suppresses residual melatonin and anchors the circadian clock, reducing the degree of circadian drift that contributes to late-day symptom emergence.
Structured Daily Routine
Consistent timing of meals, activity, and rest provides external time cues (zeitgebers) that partially compensate for impaired internal circadian signaling. Routine reduces the cognitive demand of orienting to time and context throughout the day, preserving more reserve for the late-afternoon window.
Environmental Modification
Reducing sensory stimulation — noise, visual clutter, social demands — in the hours preceding the typical sundowning window can reduce the accumulated load that depletes compensatory capacity. Maintaining indoor lighting through the late afternoon delays the loss of light-based orienting cues. Familiar auditory stimuli, particularly music from the individual's young adult years, have shown anecdotal and some clinical benefit as grounding anchors when verbal reorientation fails.
Caregiver Regulation
Research on caregiver burden consistently documents that caregiver emotional dysregulation amplifies behavioral symptoms in care recipients. The late afternoon is the point of maximum depletion for both parties. Strategies that preserve caregiver capacity — scheduled respite, task batching earlier in the day, planned transitions before the peak window — are clinically relevant, not merely self-care recommendations.
Pharmacological Considerations
When non-pharmacological approaches are insufficient, medication management should be directed by the treating physician. Low-dose melatonin has been studied as a circadian anchor with a favorable side effect profile. Antipsychotics carry a black box warning for use in elderly patients with dementia-related psychosis and should be used only when clinically necessary and with informed consent regarding risks. This is a decision for your medical team — not a protocol to initiate independently.
What to Tell Your Care Team
If you are observing late-day behavioral escalation in someone you care for, document the following before your next appointment:
- Approximate time of onset each day (track for one week minimum)
- Duration of the symptomatic window
- Specific behaviors observed
- Any environmental or activity changes that appear to worsen or improve symptoms
- Current sleep quality and nighttime waking patterns
- Any medications taken in the afternoon or evening
This documentation moves the clinical conversation from "they get upset sometimes" to a pattern-based, actionable presentation. Your observations are data. Treat them that way.
Related RNA Resources
- Brain Injury 101 — Educational Library
- Nest Academy — Peer-Reviewed Deep Dives
- Veterans Blog — TBI and Military Brain Injury Resources
- The Nesting Journal — Sundowning: The Caregiver's Version
📬 Free Weekly Education — From the Nest
From the Nest delivers peer-reviewed brain injury and dementia education every Wednesday at 7am ET — translated for caregivers, not clinicians. Free. No spam.
Peer-Reviewed Sources
- Canevelli M, Valletta M, Trebbastoni A, et al. Sundowning in Dementia: Clinical Relevance, Pathophysiological Determinants, and Therapeutic Approaches. Frontiers in Medicine. 2016;3:73.
- Volicer L, Harper DG, Manning BC, Goldfeder R, Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. American Journal of Psychiatry. 2001;158(5):704–711.
- Khachiyants N, Trinkle D, Son SJ, Kim KY. Sundown Syndrome in Persons with Dementia: An Update. Psychiatry Investigation. 2011;8(4):275–287.
- Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database of Systematic Reviews. 2014;(2):CD003946.
- Bedrosian TA, Nelson RJ. Sundowning syndrome in aging and dementia: Research in mouse models. Experimental Neurology. 2013;243:67–73.
- National Institute on Aging. Tips for Coping with Sundowning. nia.nih.gov.
All sources are peer-reviewed and publicly accessible. Robbins Nest Alliance does not provide medical advice. Consult your physician or care team for diagnosis and treatment decisions.